VERTEX PHARMACEUTICALS INC (1VRTX.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:1VRTX - US92532F1003 - Common Stock
334.7 EUR
-2.05 (-0.61%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.931B 17.91% | 9.869B 10.51% | 11.02B 11.66% | 12.221B 10.90% | 13.391B 9.57% | 14.576B 8.85% | 16.108B 10.51% | 17.898B 11.11% | 19.791B 10.58% | 20.984B 6.03% | 23.078B 9.98% | |
| EBITDA YoY % growth | 4.584B 57.66% | 4.54B -0.96% | 4.603B 1.37% | 5.52B 19.93% | 6.705B 21.47% | 7.408B 10.48% | 7.501B 1.26% | 8.155B 8.72% | 8.866B 8.72% | 9.49B 7.04% | 11.313B 19.21% | |
| EBIT YoY % growth | 4.436B 59.44% | 4.359B -1.73% | 4.396B 0.84% | 5.397B 22.78% | 6.327B 17.23% | 6.958B 9.97% | 7.47B 7.36% | 8.428B 12.82% | 8.996B 6.74% | 9.778B 8.69% | 10.875B 11.22% | |
| Operating Margin | 49.67% | 44.17% | 39.89% | 44.16% | 47.25% | 47.74% | 46.37% | 47.09% | 45.46% | 46.60% | 47.12% | |
| EPS YoY % growth | 14.89 14.36% | 15.22 2.22% | 0.29 -98.09% | 18.43 6,256.61% | 20.94 13.60% | 23.01 9.86% | 25.21 9.56% | 28.74 14.00% | 31.02 7.97% | 33.69 8.60% | 38.07 13.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.72 7.66% | 5.09 27.82% | 5.21 28.38% | 5.35 18.34% | 5.06 7.21% | 4.97 -2.36% |
| Revenue Q2Q % growth | 3.116B 12.41% | 3.271B 12.33% | 3.204B 15.66% | 3.315B 11.82% | 3.339B 7.16% | 3.378B 3.27% |
| EBITDA Q2Q % growth | 1.423B 10.14% | 1.567B 18.65% | 1.776B 64.86% | 1.698B 35.47% | 1.598B 12.30% | 1.4B -10.66% |
| EBIT Q2Q % growth | 1.398B 23.57% | 1.531B 37.49% | 1.586B 54.15% | 1.614B 39.95% | 1.556B 11.30% | 1.48B -3.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.52 135.23% | 4.37 | 0.15 | 3.45% |
| Q1 2025 Q2Q % growth | 4.06 -14.71% | 4.37 | -0.31 | -7.20% |
| Q4 2024 Q2Q % growth | 3.98 -5.24% | 4.11 | -0.13 | -3.07% |
| Q3 2024 Q2Q % growth | 4.38 7.35% | 4.22 | 0.16 | 3.69% |
| Q2 2024 Q2Q % growth | -12.83 -429.82% | 3.00 | -15.83 | -527.57% |
| Q1 2024 Q2Q % growth | 4.76 56.07% | 4.14 | 0.62 | 14.85% |
| Q4 2023 Q2Q % growth | 4.20 11.70% | 4.18 | 0.02 | 0.36% |
| Q3 2023 Q2Q % growth | 4.08 1.75% | 4.05 | 0.03 | 0.66% |
| Q2 2023 Q2Q % growth | 3.89 8.06% | 3.96 | -0.07 | -1.75% |
| Q1 2023 Q2Q % growth | 3.05 -13.35% | 3.06 | -0.01 | -0.21% |
| Q4 2022 Q2Q % growth | 3.76 11.57% | 3.58 | 0.18 | 4.95% |
| Q3 2022 Q2Q % growth | 4.01 12.64% | 3.72 | 0.29 | 7.89% |
| Q2 2022 Q2Q % growth | 3.60 15.76% | 3.55 | 0.05 | 1.44% |
| Q1 2022 Q2Q % growth | 3.52 18.12% | 3.56 | -0.04 | -1.18% |
| Q4 2021 Q2Q % growth | 3.37 34.26% | 3.37 | 0.00 | 0.13% |
| Q3 2021 Q2Q % growth | 3.56 34.85% | 3.14 | 0.42 | 13.27% |
| Q2 2021 Q2Q % growth | 3.11 19.16% | 2.56 | 0.55 | 21.59% |
| Q1 2021 Q2Q % growth | 2.98 16.41% | 2.74 | 0.24 | 8.66% |
| Q4 2020 Q2Q % growth | 2.51 | 2.64 | -0.13 | -5.00% |
| Q3 2020 Q2Q % growth | 2.64 | 2.39 | 0.25 | 10.49% |
| Q2 2020 Q2Q % growth | 2.61 | 2.12 | 0.49 | 23.38% |
| Q1 2020 Q2Q % growth | 2.56 | 1.88 | 0.68 | 36.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.965B 12.06% | 2.963B | 1.7M | 0.06% |
| Q1 2025 Q2Q % growth | 2.77B 2.96% | 2.91B | -139.8M | -4.80% |
| Q4 2024 Q2Q % growth | 2.912B 15.66% | 2.836B | 76M | 2.68% |
| Q3 2024 Q2Q % growth | 2.772B 11.61% | 2.778B | -6.1M | -0.22% |
| Q2 2024 Q2Q % growth | 2.646B 6.11% | 2.715B | -69.4M | -2.56% |
| Q1 2024 Q2Q % growth | 2.691B 13.30% | 2.63B | 60.6M | 2.30% |
| Q4 2023 Q2Q % growth | 2.518B 9.34% | 2.564B | -46.3M | -1.81% |
| Q3 2023 Q2Q % growth | 2.484B 6.39% | 2.55B | -66.5M | -2.61% |
| Q2 2023 Q2Q % growth | 2.493B 13.52% | 2.468B | 25.2M | 1.02% |
| Q1 2023 Q2Q % growth | 2.375B 13.22% | 2.384B | -9.2M | -0.39% |
| Q4 2022 Q2Q % growth | 2.303B 11.10% | 2.347B | -44.3M | -1.89% |
| Q3 2022 Q2Q % growth | 2.334B 17.65% | 2.271B | 63.3M | 2.79% |
| Q2 2022 Q2Q % growth | 2.196B 22.46% | 2.175B | 21.2M | 0.97% |
| Q1 2022 Q2Q % growth | 2.098B 21.64% | 2.118B | -20.5M | -0.97% |
| Q4 2021 Q2Q % growth | 2.073B 27.32% | 2.043B | 29.561M | 1.45% |
| Q3 2021 Q2Q % growth | 1.984B 28.99% | 1.893B | 91.164M | 4.82% |
| Q2 2021 Q2Q % growth | 1.793B 17.64% | 1.752B | 41.37M | 2.36% |
| Q1 2021 Q2Q % growth | 1.724B 13.81% | 1.69B | 34.305M | 2.03% |
| Q4 2020 Q2Q % growth | 1.628B | 1.616B | 11.82M | 0.73% |
| Q3 2020 Q2Q % growth | 1.538B | 1.515B | 23.271M | 1.54% |
| Q2 2020 Q2Q % growth | 1.524B | 1.413B | 111.485M | 7.89% |
| Q1 2020 Q2Q % growth | 1.515B | 1.313B | 202.107M | 15.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.02% | 1.8% | 0.71% | -0.04% |
| Revenue | 0.39% | 1.43% | 0.43% | 0.22% |